Benign Conditions

Benign Prostatic Hyperplasia

Bladder Cancer

Female Urology

Genitourinary Cancers

Genomic Testing

Hormone Therapy

Kidney Cancer

Challenging Anatomy

Innovative Techniques

Laser Lithotripsy

PCNL Tech & Devices

Ureteroscopy Tech & Devices

Kidney Stones

Men's Health

Next-Generation Imaging

Voiding Dysfunction

OAB and Incontinence

Pediatrics

Controveries in Urologic Cancer

Drug Therapy

Prostate Cancer

Sexual Dysfunction

UTUC

Cosmetic Surgery

Urologic Surgery

Business

Practice Management

Malpractice Consult

Health Law & Policy

Media

Case-Based Peer Perspectives

Investigator Perspectives 

Medical World News

Podcasts

Urology Medical Perspectives

UTv Videos

Peer Exchange

Special Report

Virtual Tumor Board

Insights

Medcast

Peers & Perspectives

Conferences

Conference Listing

Conference Previews 

Conference Recaps

Publications

Urology Times Journal

Editorial Advisory Board

Urologists in Cancer Care

Supplements and Featured Publications

Clinical Forums Recaps

CME/CE

Resources

Begin Your Journey: Tackling Burnout

Live Events

Interactive Tools

Job Board

Partners

Treatment Landscape Evolutions

Subscribe

Articles

"Glean will enable patients to void naturally, without catheters in place. I believe this advance will yield a better test that mimics actual symptoms," says Bilal I. Chughtai, MD. 

FDA grants 510(k) clearance to Glean Urodynamics System

professor and chair of urology at the University of Oklahoma Health Sciences Center in Oklahoma City, is co-editor in chief of 

"We must lobby to maintain our current funding levels and push for increased support to continue driving progress in cancer care," says Michael S. Cookson, MD, MMHC, FACS.

The importance of federal funding in cancer research: A call to action

“The data presented at EAU25 add to the growing body of evidence supporting the CVAC System as the emerging standard of care in kidney stone removal,” says Brett Johnson, MD. 

CVAC2 shows safety, efficacy for stone clearance in real-world study

A recap of the FDA submissions and regulatory decisions in urology from March 2025.

FDA updates in urology: March 2025

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

About Us

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do not sell my Personnal Information

Urology Times | News & Insights for Urologists & Health Professionals

Facebook

LinkedIn

Spotlight

Peers and Perspectives

Clinical

Virtual Events

1rem

Around the Practice | Improving Outcomes in Advanced Prostate Cancer

Register for our live, interactive cross-fire style event featuring multidisciplinary experts in oncology & urology discussing leading topics in 

Participate in our live audience polling with real-time Q&A throughout the event to share how you would treat each patient case.

Updates in the Treatment of Metastatic Castration-sensitive Prostate Cancer

Choosing an Optimal Therapy for Patients with Metastatic Castration-resistant Prostate Cancer

Around the Practice: October 2021

Join us for the July installment of Around the Practice. Our virtual monthly GU oncology live case event is presented in partnership with LUGPA. Each month, we feature leading experts representing urologists, pathologists, as well as radiation, surgical, and medical oncologists who discuss challenging patient cases, answer questions, and conduct live audience polling.

Our event is complimentary. Information on featured speakers and specific discussion topics will be updated closer to the event date. After you register, please check your inbox and our website for the latest information on Around the Practice. Each live case event is co-moderated by Raoul S. Concepcion, MD, FACS, from Nashville, TN, and/or Jason Hafron, MD, from Troy, MI.

BCG-Unresponsive, Non-Muscle Invasive Bladder Cancer

Muscle Invasive Bladder Cancer, treated with neoadjuvant therapy, node+ disease at cystectomy

Around the Practice: July 2021

 is presented in partnership with LUGPA. Each month, we feature 

 who discuss challenging patient cases, answer questions, and conduct live audience polling.

This month, we will answer the following questions as we discuss challenging patient cases:

How are people viewing somatic germline in both cases?

What is the application of genetic testing in urology?

Newly diagnosed high grade, high-risk prostate cancer

Heavily treated, metastatic castrate-resistant prostate cancer

Around the Practice: June 2021

Join us for the May installment of Around the Practice. Our virtual monthly GU oncology live case event is presented in partnership with LUGPA. Each month, we feature leading experts representing urologists, pathologists, as well as radiation, surgical, and medical oncologists who discuss challenging patient cases, answer questions, and conduct live audience polling.

PARP inhibitor for the treatment of metastatic castrate resistant prostate cancer

Immunotherapy monotherapy for the treatment of BCG-unresponsive non-muscle invasive bladder cancer

Novel hormone therapy for the treatment of non-metastatic castrate resistant prostate cancer

Around the Practice: May 2021

Join us for the April installment of Around the Practice. Our virtual monthly GU oncology live case event is presented in partnership with LUGPA. Each month, we feature leading experts representing urologists, pathologists, as well as radiation, surgical, and medical oncologists who discuss challenging patient cases, answer questions, and conduct live audience polling.

Metastatic castrate-resistant prostate cancer

Around the Practice: April 2021

Register for our live, interactive event featuring leaders in oncology reviewing and discussing patient cases. Our experts will conduct live audience polling and answer your questions throughout the event. Our monthly event is presented in partnership with LUGPA.

Around the Practice: March 2021 

: Around the Practice: Detecting Biochemical Recurrence in Prostate Cancer

Register for our live, interactive event featuring leaders in oncology discussing leading topics in Prostate Cancer. Participate in our live audience polling with real-time Q&A throughout the event.

Overview of Biochemical Recurrence After Prostatectomy

Molecular Imaging Approaches to Detecting Biochemical Recurrence After Prostatectomy

Unanswered Questions and Future Directions in Personalizing Salvage Therapy in Recurrent Prostate Cancer

Around the Practice: Detecting Biochemical Recurrence in Prostate Cancer, a special CancerNetwork® event

Register for our live, interactive event featuring leaders in oncology reviewing and discussing patient cases. Participate in our live audience polling with real-time Q&A throughout the event. Our monthly Urological Virtual Tumor Board is presented in partnership with LUGPA.

Localized, high-risk prostate cancer  with oligometastasis at diagnosis

Around the Practice: February 2021 

Register for a live, interactive event featuring leaders in oncology reviewing and discussing patient cases in Bladder Cancer/Renal Carcinoma.